NCAPH and posterior cortical atrophy: In conclusion, our results indicate that NCAPH-KD can synergistically enhance the anti-proliferative effects of Eve or Flav on PCa cells both in vitro and in vivo, suggesting that NCAPH is a potential therapeutic target for PCa treatment.